Central European Journal of Immunology

📢 The new issue of the Central European Journal of Immunology is now available: 2/2026, Vol. 51.

This issue features research and reviews covering immunometabolism, tuberculosis, autoimmune diseases, sepsis, anti-tumor immunity, macrophage biology, cancer, primary immunodeficiency, COVID-19, and venous thrombosis.

Take a look at this number EDITOR’S PICK

Editorial:
Glutaminolysis as a metabolic checkpoint of protective Th1/Th17 immunity against Mycobacterium tuberculosis
Urszula Radzikowska, Sylwia Smolińska, Marlena Tynecka, Andrzej Eljaszewicz
Cent Eur J Immunol 2026;51(2):109–110
DOI: https://doi.org/10.5114/ceji/226300

Full paper:
Glutaminase 1-mediated glutaminolysis regulates tuberculosis progression by modulating Th1 and Th17 immune responses
Xiaozhen Cai, Yidan Huang, Lili Zeng, Rong Rong
Cent Eur J Immunol 2026;51(2):121–132
DOI: https://doi.org/10.5114/ceji/208684

📖 REVIEW PAPER

HE4: a potential diagnostic biomarker in autoimmune diseases
Qinni Yang
Cent Eur J Immunol 2026;51(2):111–120
DOI: https://doi.org/10.5114/ceji/208686

🧪 ALL ORIGINAL PAPERS

Glutaminase 1-mediated glutaminolysis regulates tuberculosis progression by modulating Th1 and Th17 immune responses
Xiaozhen Cai, Yidan Huang, Lili Zeng, Rong Rong
Cent Eur J Immunol 2026;51(2):121–132
DOI: https://doi.org/10.5114/ceji/208684

The AGO2–ATOX1 axis exacerbates inflammation in a mouse sepsis model
Peng Huang, Meiling He, Xiangyang Mo, Lipu Deng
Cent Eur J Immunol 2026;51(2):133–147
DOI: https://doi.org/10.5114/ceji/209136

Expanded dendritic cells loaded with placental gp96 to generate antigen-specific T cells for anti-tumor immunity: an in vitro study
ChengShi Lin, Yu Lin, PingQing Lin, NengPing Huang, YongQing Ye
Cent Eur J Immunol 2026;51(2):148–157
DOI: https://doi.org/10.5114/ceji/204676

Musculin enhances the immune function of peritoneal macrophages in mice
Yu Xia, Xin Zhang, Jing Yu, Guochang Liu, Daiqi Chen, Lu Kang, Yun Wang, Jun Yan
Cent Eur J Immunol 2026;51(2):158–166
DOI: https://doi.org/10.5114/ceji/205378

CircHMGA2 facilitates proliferation and invasion of laryngeal squamous cell carcinoma cells and M2 macrophage polarization via the miR-384/ROCK1 axis
Zhenjun Wang, Ping Wu, Li Li, XianHua Zhu, Yueyong Xiao
Cent Eur J Immunol 2026;51(2):167–183
DOI: https://doi.org/10.5114/ceji/207758

B cells, autoimmunity, and innate immunity in 22q11.2 deletion syndrome: a two-center study and review of the literature
Ezgi Topyildiz, Selime Ozen Boluk, Ilke Baş, Emine Ulgen, Nesrin Gulez, Neslihan Edeer Karaca, Ferah Genel, Guzide Aksu, Necil Kutukculer
Cent Eur J Immunol 2026;51(2):184–196
DOI: https://doi.org/10.5114/ceji/208683

Uncovering common pathways and potential drug targets in COVID-19 and venous thrombosis via systems biology approaches
Boyang Yu, Rongjian Gao, Wenchao Ma
Cent Eur J Immunol 2026;51(2):197–222
DOI: https://doi.org/10.5114/ceji/201957

We invite you to explore the full issue and read the latest contributions to immunology research.

📢 News from CEJI!

We are pleased to announce that the Central European Journal of Immunology (CEJI) has launched a new website along with updated Author Guidelines! 🎉

🔹 The new website offers clearer navigation, easier access to published articles, early view (papers ahead of print (new!), Editor's Pick, and journal information, and a more user-friendly experience for both Authors and Readers.
🔹 The updated Author Guidelines have been refined and standardized to support authors in preparing their manuscripts and to streamline the review and publication process. New options, such as Graphical Abstract (for original papers), are now available!

👉 We warmly encourage you to visit our new website, explore its features, and carefully review the updated Author Guidelines before submitting your manuscript.

Thank you for being part of the CEJI community and for contributing to the advancement of immunology research!

New webpage: https://ceji.termedia.pl